If the Mammoth Comes Back in 2032

Biotech and AI cells imagery representing the de-extinction frontier.

AI summary

  • Colossal Biosciences, founded 2021 by George Church and Ben Lamm, is targeting 2028 for the first live mammoth-elephant hybrid calves. 2032 is the year by which a small founder herd could plausibly exist.
  • What gets “brought back” is not a pure mammoth. It is an Asian elephant whose genome has been edited at the cold-adaptation loci that distinguish mammoth from elephant: hemoglobin, shaggy coat, smaller ears, subcutaneous fat, sebaceous glands.
  • The real argument for doing this is not nostalgia. It is the Pleistocene Park hypothesis: mammoth-grade megaherbivores compacted Arctic snow and kept tundra cold enough to preserve carbon-rich permafrost. Restoring that ecosystem function may be a meaningful climate intervention.
  • If 2032 arrives with a healthy hybrid calf alive in Siberia, the next ten years are about scaling the herd, measuring whether the ecological-engineering claim is real, and writing the legal frameworks for a creature that is genuinely new.
  • The honest case for skepticism is also real. Animal welfare for the surrogate elephants. Ecological unknowns. The Asian elephant being endangered already. None of these are deal-breakers, all of them deserve serious answers.

This is a thought experiment, not a prediction. The point of running one is to take a specific, well-defined future and reason carefully about what it would mean. If the woolly mammoth comes back in 2032, in the form Colossal Biosciences has been openly aiming for, what does the world actually look like? What works? What does not? What are the second-order effects most coverage misses?

For background on the company, the chick-from-an-artificial-egg breakthrough, and the broader biotech frontier, the Colossal eggshell chick post and the Biotech Frontier hub are the right places to start. This piece picks up where those leave off and runs the scenario forward.

What does “bringing back the mammoth” actually mean?

Most coverage gets this wrong, so it is worth being precise. There is no jar of pristine mammoth DNA waiting to be turned into a calf. The DNA in frozen mammoth tissue has been fragmented for thousands of years. What Colossal’s program does is genetically much more interesting than the headline version.

The starting point is the Asian elephant, the closest living relative of the mammoth. Asian elephants and mammoths share about 99.6 percent of their genome. The differences are concentrated at specific loci that gave mammoths their cold-adaptation traits: a modified hemoglobin that delivers oxygen at low temperatures, a thicker subcutaneous fat layer, smaller ears (less heat loss), sebaceous and Meibomian glands that produced the shaggy outer coat. Colossal’s program is identifying these mammoth alleles, editing them into an Asian elephant cell line, growing the edited embryos to viability, and gestating them in a surrogate.

The result is what the field calls a “functional mammoth” or, more honestly, a cold-adapted Asian elephant. It is a new kind of organism that does most of what a mammoth did ecologically, without being a mammoth in any species-purity sense. Some people find that disappointing. The right framing is that this is not less impressive than de-extinction, it is a different and arguably more important capability: the engineering of large mammals to fit ecological niches we want filled.

Why mammoth, specifically?

The headline answer is wonder. Most journalists writing about Colossal cannot quite hide their delight at the idea, and most readers feel the same pull. That is a perfectly good reason for the project to exist, and it is not why scientists like Beth Shapiro and George Church spend their careers on it.

The serious reason is permafrost. The Arctic tundra holds something on the order of 1,500 gigatons of carbon, twice what is currently in the atmosphere. As the Arctic warms, that carbon enters the atmosphere as methane and CO2 in a feedback loop that meaningfully accelerates global warming. The Pleistocene Park hypothesis, advanced by Russian ecologists Sergey and Nikita Zimov over decades, is that the mammoth-steppe ecosystem actively kept the Arctic colder than today’s tundra does. Megaherbivores trampled snow, exposing the ground to deeper winter cold. They grazed back the dwarf shrubs whose dark leaves absorb summer sun. The ecosystem cooled itself.

The hypothesis is not universally accepted. Some climate ecologists argue the effect is too small to matter at scale. Others argue the timeline mismatches: even a successful Colossal program produces a few thousand cold-adapted elephants over decades, against an Arctic landmass measured in millions of square kilometers. The case is not closed. But the hypothesis is testable, it is supported by direct field experiments at Pleistocene Park itself, and it represents the most concrete climate-intervention argument any de-extinction project has ever offered.

What does 2032 look like if it works?

Run the optimistic scenario forward. Colossal’s stated timeline is calves by 2028. By 2032, on a realistic four-year extension from there, the picture is:

  • A small founder herd of 20 to 50 cold-adapted Asian elephants alive in a managed reserve. Likely Pleistocene Park in Yakutia, possibly a parallel site in Alaska or northern Canada.
  • The first generation of calves born in captivity, ear- and coat-phenotyped to confirm the edited traits are expressed.
  • Behavioral and ecological monitoring underway: do these animals graze and trample at densities that reproduce mammoth-steppe dynamics? Do they survive Siberian winters as the genome predicts?
  • A separate population of artificial-uterus calves, if the supporting technology matures. Colossal has been clear that the artificial-uterus path is a parallel research track to surrogate gestation in Asian elephants.
  • Substantial scientific publications on cold-adaptation gene expression, surrogate-elephant welfare, and the early ecological data.
  • A regulatory and legal framework still being written in real time. CITES, the US Endangered Species Act, Russian wildlife law, and international scientific bodies all need to weigh in.

2032 is not the year you have mammoth herds doing measurable climate work. It is the year you have proof-of-concept that the underlying engineering produces a viable animal. The ecological-engineering claim takes another decade or two to validate at scale.

What would Colossal’s other projects look like by then?

Mammoth is the flagship but not the only program. By 2032, on the same trajectory:

  • The thylacine (Tasmanian tiger) project is using the fat-tailed dunnart as the marsupial surrogate, and the genome of the thylacine is more recoverable than the mammoth’s. A live thylacine-analog could conceivably arrive before 2032.
  • The dodo program builds on Nicobar pigeon biology. The recent artificial-eggshell chicks news from May 2026 is direct progress on the avian-incubation side of that project.
  • The dire wolf, brought back through Aenocyon-edited gray wolf cell lines, is the case where the science actually arrived first. Healthy pups were born in 2024. By 2032 there is likely a small managed population.
  • The conservation arm, applied to existing endangered species, has cumulatively done more measurable good than any single de-extinction. The northern white rhino program in particular is on track.

The pattern across the portfolio is that the techniques developed for de-extinction are immediately useful for conserving species that are still alive but in trouble. That is probably the most important second-order effect of Colossal’s existence as a company, independent of whether any individual de-extinction “succeeds” in the public-imagination sense.

What are the serious objections?

The animal welfare case for the surrogate Asian elephants is the strongest objection, and the one Colossal takes most seriously. Elephant gestation is 22 months. Surrogate failures are physiologically expensive for the mother. The artificial-uterus parallel track exists in large part because the program cannot ethically scale through Asian elephant surrogates alone. Watch this part of the program closely. A version of the mammoth project that imposes serious welfare cost on its surrogate population is a version that does not deserve to succeed.

The ecological-unknowns case is the second. The mammoth steppe was a real ecosystem ten thousand years ago. Today’s Siberian tundra is a different ecosystem, with permafrost, shrub layers, and wildfire dynamics that did not exist in the same form during the Pleistocene. There is no guarantee that a cold-adapted elephant introduced today behaves the way mammoths behaved then. Honest field ecologists will tell you the experiment is worth running and the outcome is genuinely uncertain.

The opportunity-cost case is third. The capital and talent Colossal absorbs could go into Asian elephant conservation, climate engineering at scale, or basic genome biology elsewhere. The reply is that the donors and investors funding Colossal would mostly not be funding those alternatives, and the techniques developed transfer broadly anyway. Both are reasonable readings.

The Jurassic Park case (this is a slippery slope to bad things) is the weakest, but it is the one journalists like best. There is no path from a cold-adapted Asian elephant to a velociraptor. Different timescales, different DNA preservation, different biology. Treating the projects as the same kind of thing is a category error.

What is the most important second-order effect?

If the program works, the more important change is not the existence of a hybrid mammoth. It is the proven existence of a pipeline that can engineer large vertebrates to fit specific ecological roles. Apply that pipeline to the next century of climate adaptation and the implications are large.

Heat-tolerant cattle for the equatorial belt as average temperatures rise. Salt-tolerant crops were already being engineered before any of this. Mosquito populations are being modified to suppress malaria-vector species. The mammoth program is, viewed at the right zoom level, a particularly photogenic example of a broader capability that biotechnology was always going to develop. The right question is not whether we use the capability, the right question is what governance and what intent we apply to it.

Frequently asked questions

Is a Colossal mammoth a “real” mammoth?

No, and Colossal does not claim it is. The animal is an Asian elephant with mammoth alleles edited in at cold-adaptation loci. It is genetically and behaviorally closer to a mammoth than any other living organism, and it is not species-pure.

Could mammoths actually help with climate change?

The hypothesis is plausible and worth testing. The scale at which it would matter for global climate requires herds large enough to ecologically alter millions of square kilometers, which is many decades away even on the optimistic timeline. As a near-term climate intervention, the program is more useful as a proof-of-concept for ecological-engineering at large than as a direct mitigation.

Where would mammoth-elephant hybrids live?

Pleistocene Park in Yakutia is the lead site, with ongoing partnership between Colossal and the Zimov family who run the park. Alaska and northern Canada are credible secondary sites. Any deployment requires national and international regulatory approval that is not currently in place.

When can I see one in person?

If everything works on schedule, the first public viewings would be late this decade in a controlled-access reserve. Standard zoo visits are not the model. The animals will be a small, ecologically-monitored population for years before anything like broad access is plausible.

The Beginners in AI position on de-extinction

Most of the technology stories we cover at this site live in a future that arrives by software update. De-extinction is in a different category. The timelines are measured in elephant gestations, not GitHub releases. The technology developed at Colossal will outlast the company, outlast the current generation of investors, and outlast the news cycle that the first calf will briefly dominate. We are interested in technology stories that compound over decades.

The pro-human-first framing here is also unusual. The most defensible version of the de-extinction story is not “we are restoring lost wonders” (which is true and not enough). It is “we are developing the capability to engineer large mammals to fit the world we have changed, and we are using mammoths as the visible proof case.” Stated that bluntly, it is harder to be uncritically excited. It is also harder to dismiss. The capability is coming whether the mammoth project specifically succeeds or not, and the smartest place to be on the question is reading carefully and asking better questions than the press is asking.

If you are reading this on a Friday morning, the takeaway is: keep paying attention. The next two years will produce the early test results that determine whether 2032 is a real or aspirational date. Read the actual publications, watch the surrogate-welfare data, and remember that the most important part of this story is not the animal, it is the toolkit.

Sources

Get Smarter About AI Every Morning

Free daily newsletter. One story, one tool, one tip. Plain English, no jargon.

Free forever. Unsubscribe anytime.

You might also like

Discover more from Beginners in AI

Subscribe now to keep reading and get access to the full archive.

Continue reading